AU2002303430A1 - Compositions and methods for the diagnosis and treatment of tumor - Google Patents

Compositions and methods for the diagnosis and treatment of tumor

Info

Publication number
AU2002303430A1
AU2002303430A1 AU2002303430A AU2002303430A AU2002303430A1 AU 2002303430 A1 AU2002303430 A1 AU 2002303430A1 AU 2002303430 A AU2002303430 A AU 2002303430A AU 2002303430 A AU2002303430 A AU 2002303430A AU 2002303430 A1 AU2002303430 A1 AU 2002303430A1
Authority
AU
Australia
Prior art keywords
tumor
diagnosis
compositions
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002303430A
Other languages
English (en)
Other versions
AU2002303430A8 (en
Inventor
Avi J. Ashkenazi
Dan L. Eaton
Audrey Goddard
Austin L. Gurney
William I. Wood
Thomas D. Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of AU2002303430A1 publication Critical patent/AU2002303430A1/en
Publication of AU2002303430A8 publication Critical patent/AU2002303430A8/xx
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU2002303430A 2002-04-23 2002-04-23 Compositions and methods for the diagnosis and treatment of tumor Abandoned AU2002303430A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2002/012619 WO2003090600A2 (fr) 2002-04-23 2002-04-23 Compositions et procedes permettant de diagnostiquer et de traiter une tumeur

Publications (2)

Publication Number Publication Date
AU2002303430A1 true AU2002303430A1 (en) 2003-11-10
AU2002303430A8 AU2002303430A8 (en) 2003-11-10

Family

ID=29268416

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002303430A Abandoned AU2002303430A1 (en) 2002-04-23 2002-04-23 Compositions and methods for the diagnosis and treatment of tumor

Country Status (2)

Country Link
AU (1) AU2002303430A1 (fr)
WO (1) WO2003090600A2 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2149768T3 (es) * 1992-03-25 2000-11-16 Immunogen Inc Conjugados de agentes enlazantes de celulas derivados de cc-1065.
US6410507B1 (en) * 1997-12-24 2002-06-25 Corixa Corporation Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
CA2383254A1 (fr) * 1999-06-02 2000-12-07 Genentech, Inc. Polypeptides transmembranaires secretes et acides nucleiques codants pour ceux-ci

Also Published As

Publication number Publication date
AU2002303430A8 (en) 2003-11-10
WO2003090600A2 (fr) 2003-11-06
WO2003090600A3 (fr) 2004-08-19

Similar Documents

Publication Publication Date Title
WO2004030615A8 (fr) Compositions et procedes de diagnostic et de traitement de tumeur
EP1571968A3 (fr) Compositions et methodes permettant de diagnostiquer et de traiter une tumeur
WO2004016225A8 (fr) Compositions et methodes de diagnostic et de traitement des tumeurs
WO2004045516A9 (fr) Compositions et methodes pour le diagnostic et le traitement d'une tumeur
EP1572091A3 (fr) Compositions et methodes de diagnostic et de traitement de tumeurs
WO2004060270A8 (fr) Compositions et methodes pour diagnostiquer et traiter des tumeurs
EP1571968A4 (fr) Compositions et methodes permettant de diagnostiquer et de traiter une tumeur
WO2003057160A8 (fr) Compositions et methodes de diagnostic et de traitement d'une tumeur
EP1572091A4 (fr) Compositions et methodes de diagnostic et de traitement de tumeurs
EP1553912A4 (fr) Compositions et methodes pour le diagnostic et pour le traitement d'une tumeur
AU2003302892A1 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
WO2003072035A8 (fr) Compositions et methodes de traitement de maladies relatives au systeme immunitaire
WO2004041170A9 (fr) Compositions et methodes pour le traitement de maladies liees au systeme immunitaire
AU2002251841A1 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer
WO2004024097A9 (fr) Compositions et methodes de traitement de maladies de nature immune
AU2002251844A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2003300368A1 (en) Methods and compositions for the diagnosis, prognosis, and treatment of cancer
AU2002311909A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2003290605A1 (en) Compositions and methods for the diagnosis and treatment of sepsis
WO2005003154A8 (fr) Compositions et methodes de diagnostic et de traitement de tumeur
AU2002303219A1 (en) Compositions and methods for the therapy and diagnosis of cancer
AU2002359330A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2003237792A1 (en) Compositions and methods for the diagnosis and treatment of tumor
AU2002313726A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2003219160A1 (en) Methods and compositions for the treatment of cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase